Skip to main content

Table 5 Variations in blood pressure and serum potassium before and after treatment in two groups

From: Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study

Indexes

Times

Sacubitril/valsartan (n = 106)

Valsartan (n = 106)

P

SBP (mmHg)a

Baseline

146.35 ± 20.19

148.27 ± 26.53

0.553

16 weeks

130.94 ± 22.87***

146.49 ± 23.01

< 0.001

DBP (mmHg)a

Baseline

82.01 ± 13.18

82.57 ± 13.78

0.764

16 weeks

79.41 ± 13.55

80.38 ± 14.05

0.609

potassium (mmol/L)a

Baseline

4.18 ± 0.42

4.20 ± 0.38

0.674

16 weeks

4.22 ± 0.48

4.30 ± 0.42

0.170

  1. SBP systolic blood pressure, DBP diastolic blood preessure
  2. a T test
  3. Data with normal distribution is represented as mean ± standard deviation
  4. ***P < 0.001 compared with before treatment